Serum creatine kinase activity varies with ovulatory status in regularly exercising, premenopausal women.
OBJECTIVE
The clinical complications associated with an unopposed estrogen environment and luteal phase defects observed in exercising women prompted the examination of the relationship of exercise and endogenous ovarian steroids with serum creatine kinase (CK) activity.


METHODS
Subjects (n = 34) were classified into three groups according to their exercise and menstrual status, sedentary and exercising ovulatory groups (SedOvul, ExOvul), and an exercising amenorrheic group (ExAmen). Daily urine samples were collected to assess urinary ovarian steroid exposure and menstrual status. Serum CK activity was assayed in each menstrual cycle of all subjects.


RESULTS
Exercise increased serum CK activity in all exercising subjects (p < 0.01), but the increase was greater in amenorrheic women compared to ovulatory women (SedOvul: 33.0 +/- 3.4; ExOvul: 43.7 +/- 4.1; ExAmen: 54.4 +/- 3.6, p < 0.05). When the ovulatory women were further divided into those with normal steroid production (ExOvul subgroup) and those with a suppressed progesterone luteal phase environment (ExLPD), both the ExOvul (51.9 +/- 5.4 IU/l) subgroup and ExAmen group had higher serum CK activity (p < 0.05) than the ExLPD (36.6 +/- 5.2 IU/l) subjects or the sedentary controls.


CONCLUSIONS
These data demonstrate the complex association between ovarian hormone status and the normal serum CK response to regular mechanical stress imposed by chronic exercise training.
Thompson
Heather S
HS
Molecular and Cellular Biology Program, University of Massachusetts, Amherst, Mass., USA.
Scordilis
Stylianos P
SP
De Souza
Mary Jane
MJ
D000293:Adolescent; D000328:Adult; D003402:Creatine Kinase / Q000097:blood*; D004967:Estrogens / Q000097:blood; D004970:Estrone / Q000097:blood; D015444:Exercise; D005260:Female; D006801:Humans; D008597:Menstrual Cycle / Q000097:blood; D009132:Muscles / Q000502:physiology; D010060:Ovulation / Q000097:blood*; D011276:Pregnanediol / Q000031:analogs & derivatives / Q000097:blood; D017697:Premenopause / Q000097:blood*; D011374:Progesterone / Q000097:blood
D004967:Estrogens; C022270:pregnanediol-3 alpha-glucuronide; D004970:Estrone; D011374:Progesterone; D003402:Creatine Kinase; D011276:Pregnanediol